Your browser doesn't support javascript.
loading
Cerebral Microbleeds and Risk of Intracerebral Hemorrhage Post Intravenous Thrombolysis.
Zand, Ramin; Tsivgoulis, Georgios; Singh, Mantinderpreet; McCormack, Michael; Goyal, Nitin; Ishfaq, Muhammad Fawad; Shahripour, Reza Bavarsad; Nearing, Katherine; Elijovich, Lucas; Alexandrov, Anne W; Liebeskind, David S; Alexandrov, Andrei V.
Afiliação
  • Zand R; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee; Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia. Electronic address: rzand@UTHSC.edu.
  • Tsivgoulis G; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee; Second Department of Neurology, "Attikon University Hospital", School of Medicine, University of Athens, Athens, Greece.
  • Singh M; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • McCormack M; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Goyal N; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Ishfaq MF; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Shahripour RB; Department of Neurology, University of Alabama, Birmingham, Alabama.
  • Nearing K; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Elijovich L; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Alexandrov AW; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Liebeskind DS; Department of Neurology, University of California, Los Angeles, California.
  • Alexandrov AV; Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
J Stroke Cerebrovasc Dis ; 26(3): 538-544, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28065404
ABSTRACT

BACKGROUND:

Stroke patients who have cerebral micro bleeds (CMBs) could be potentially at a greater risk for symptomatic intracerebral hemorrhage (sICH) than those patients without CMBs. The aim of our study was to investigate whether the presence and burden of CMBs are associated with post IVT sICH.

METHODS:

In this multicenter study, consecutive patients treated with intravenous tissue plasminogen activator were prospectively identified and analyzed. Patients without magnetic resonance imaging (MRI) within 24 hours of treatment were excluded. CMBs were defined as round or oval, hypointense lesions with associated blooming on T2*-weighted MRI up to 10 mm in diameter. Outcome measures included the occurrence of sICH or death.

RESULTS:

Of 672 patients with IVT (mean age 62 ± 14 years, 52% men, median admission NIHSS 7 points), 103 patients had CMBs on T2*-MRI. Ten patients had more than 10, whereas the remaining 93 patients had 1-10 CMBs on T2*-MRI. The rates of sICH did not differ between patients with and patients without 1-10 CMBs (5.8% versus 3.5%; P = .27). However, sICH occurred more frequently (P = .0009) in patients with > 10 CMBs (30%, 95% confidence interval [CI] by the adjusted Wald

method:

10%-61%). After adjusting for potential confounders, the presence of >10 CMBs on T2*-MRI was independently (P = .0004) associated with a higher likelihood for sICH (odds ratio [OR]13.4, 95%CI3.2-55.9).

CONCLUSIONS:

Our findings indicate an increased risk of sICH after IVT when more than 10 CMBs are present.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Cerebral / Ativador de Plasminogênio Tecidual / Fibrinolíticos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Stroke Cerebrovasc Dis Assunto da revista: ANGIOLOGIA / CEREBRO Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Cerebral / Ativador de Plasminogênio Tecidual / Fibrinolíticos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Stroke Cerebrovasc Dis Assunto da revista: ANGIOLOGIA / CEREBRO Ano de publicação: 2017 Tipo de documento: Article